- Home
- Publications
- Publication Search
- Publication Details
Title
FGF23 in Acute and Chronic Illness
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2015, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2015-09-29
DOI
10.1155/2015/358086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of burn on serum concentrations of sclerostin and FGF23
- (2015) Gordon L. Klein et al. BURNS
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk
- (2015) A. Zittermann et al. EUROPEAN JOURNAL OF NUTRITION
- Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia
- (2015) Xiaoping Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
- (2015) T. Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: An observational study in acute burn patients
- (2014) Anne-Françoise Rousseau et al. BURNS
- Impact of Parathyroidectomy on Serum FGF23 and Soluble Klotho in Hemodialysis Patients With Severe Secondary Hyperparathyroidism
- (2014) Hiroo Takahashi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes
- (2013) David E. Leaf et al. CLINICAL ENDOCRINOLOGY
- Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology
- (2013) J. Arnlov et al. Clinical Journal of the American Society of Nephrology
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Effect of a 300 000-IU Loading Dose of Ergocalciferol (Vitamin D2) on Circulating 1,25(OH)2-Vitamin D and Fibroblast Growth Factor-23 (FGF-23) in Vitamin D Insufficiency
- (2013) C. Turner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients
- (2013) Jocelyn S. Garland et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Plasma FGF23 levels increase rapidly after acute kidney injury
- (2013) Marta Christov et al. KIDNEY INTERNATIONAL
- Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects
- (2013) K. J. Martin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
- (2013) José Manuel Fernández-Real et al. PLoS One
- Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23
- (2012) S.-A. M. Burnett-Bowie et al. Clinical Journal of the American Society of Nephrology
- FGF-23 Levels in Patients with AKI and Risk of Adverse Outcomes
- (2012) D. E. Leaf et al. Clinical Journal of the American Society of Nephrology
- Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
- (2012) Justine Bacchetta et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- The role of FGF23 in CKD—with or without Klotho
- (2012) Hirotaka Komaba et al. Nature Reviews Nephrology
- High Mortality Rate of Infectious Diseases in Dialysis Patients: A Comparison With the General Population in Japan
- (2012) Minako Wakasugi et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
- (2011) M. Wolf et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
- (2011) J. Kendrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
- (2011) M. Koizumi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Parameters of Mineral Metabolism predict Midterm Clinical Outcome in End-Stage Heart Failure Patients
- (2011) Armin Zittermann et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
- FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study
- (2011) MaryAnn Zhang et al. Annals of Intensive Care
- Klotho and the Aging Process
- (2011) Makoto Kuro-o KOREAN JOURNAL OF INTERNAL MEDICINE
- Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals
- (2010) Majd A.I. Mirza et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease
- (2010) S. M. Moe et al. Clinical Journal of the American Society of Nephrology
- Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term
- (2010) Ayse Kubat Uzum et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women
- (2010) Kerrie M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The amazing osteocyte
- (2010) Lynda F Bonewald JOURNAL OF BONE AND MINERAL RESEARCH
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*
- (2009) Yukiko Aono et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started